Samsara Vision
ApprovedSamsara Vision’s next-generation ophthalmic treatments improve sight and everyday life for people with severe vision disorders.
Founded
2018
Focus
OphthalmologyMedical Devices
About
Samsara Vision’s next-generation ophthalmic treatments improve sight and everyday life for people with severe vision disorders.
Funding History
2Total raised: $225M
Series B$150MSynconaMar 15, 2023
Series A$75MSynconaJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationSaratoga, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile